 |
|
|
|
|
|
|
|
 |
Results for 'Human Growth Hormone (hGH)' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Serono Prospects to 2010
Prospects to 2010
|
November 2006 |
£795 |
50 % |
Biogenerics, The World Market
Biosimilars and Follow-On Biologics at a Crossroads
|
April 2008 |
£1765 |
47.5 % |
Opportunities in Drug Delivery
Identifying hot technologies, companies and markets
|
September 2003 |
£400 |
35 % |
Pharmaceutical Biotechnology: Fundamentals and Applications
Third Edition
|
October 2007 |
£115 |
34.65 % |
Global Protein Therapeutics Market Analysis
|
September 2007 |
£895 |
33.95 % |
Livestock Performance Products and Markets
|
January 2007 |
£895 |
33.6 % |
Sandoz Generics Company Intelligence Report
Company Intelligence Report
|
June 2008 |
£195 |
29.5 % |
When Patients Become Plaintiffs
A Primer on Drug and Medical Device Liability
|
January 2006 |
£1095 |
27 % |
Development and Commercialisation of Protein Therapeutics
Technologies, pipelines and forecasts
|
September 2004 |
£1045 |
25.2 % |
Strategies for Biogeneric Success
|
June 2004 |
£950 |
24.5 % |
Biosimilars: a viable market?
|
September 2008 |
£1295 |
23.45 % |
Global Protein Therapeutics Market, The
Market Dynamics and Pipeline Analysis
|
December 2006 |
£1490 |
22.05 % |
Novel Targets in Drug Discovery
A new era in therapy
|
April 2004 |
£595 |
21 % |
Biogenerics: Challenges and Promise
Challenges and Promise
|
January 2005 |
£495 |
19.25 % |
Global Endocrine Pharmaceutical Market 2005, The
2nd Edition
|
March 2005 |
£1499 |
18.55 % |
Prostate Cancer - A Therapeutic & Competitive Insight
Drug Pipeline Update 2007
|
May 2007 |
£1015 |
18.5 % |
Women's Health
Worldwide Prescription Drug Markets
|
August 2006 |
£1970 |
18.2 % |
Women's Health
Worldwide Prescription Drug Markets
|
August 2006 |
£1970 |
18.2 % |
Antibodies in Oncology
Drug Pipeline Update 2007
|
May 2007 |
£1015 |
18 % |
Non-Antibody Based Cancer Vaccines: Drug Pipeline Update 2006
Drug Pipeline Update 2007
|
May 2007 |
£1015 |
18 % |
Immunotherapy in Oncology
Drug Pipeline Update 2007
|
May 2007 |
£1355 |
17.5 % |
World Market for Sexual Disorders, 2005-2012, The
Traversing New Frontiers in Sexual Chemistry
|
January 2006 |
£1900 |
17.15 % |
Biotech Drug Delivery Systems
Key Company Intelligence & Market Outlook to 2012
|
February 2007 |
£1299 |
16.45 % |
Plant-Derived Drugs: Products, Technology, Applications
|
June 2006 |
£2410 |
16.45 % |
Market for Bioengineered Protein Drugs; The
|
January 2007 |
£2410 |
15.75 % |
Osteoporosis & Bone Metabolism Disorders Market
2008-2023
|
August 2008 |
£2999 |
15.05 % |
Biosimilars
Evolution or Revolution
|
September 2006 |
£1950 |
15.05 % |
Pancreatic Cancer Drug Pipeline Update 2007
|
May 2007 |
£1015 |
15 % |
Lymphoma Drug Pipeline Update 2006
|
May 2007 |
£1015 |
15 % |
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Breast- and Prostate Cancer
|
June 2007 |
£3510 |
14.7 % |
Cancer Vaccines: Aim and Shoot
|
May 2008 |
£1535 |
14.7 % |
Hematological Cancers Drug Pipeline Update 2006
|
May 2007 |
£1355 |
14.5 % |
Large Pharma:2004 a year of Progress
|
January 2005 |
£1325 |
14.5 % |
Breast Cancer Drug Pipeline Update 2006
|
May 2007 |
£1015 |
14.5 % |
Ovarian Cancer Drug Pipeline Update 2007
|
May 2007 |
£1015 |
14.5 % |
Lead Optimization Strategies
An analysis of novel molecular targets to develop innovative new therapeutics
|
January 2005 |
£1495 |
14 % |
Biosimilars: Benchmarking the key players
With increasing regulatory clarity and high revenue potential, interest in biosimilars increases
|
December 2006 |
£4000 |
14 % |
CRC Drug Pipeline Update 2005
|
May 2007 |
£1015 |
14 % |
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Leukemias and Lymphomas
|
June 2007 |
£3510 |
13.65 % |
Currently Druggable in Breast Cancer: A Drug Target Competitive Analysis
|
August 2008 |
£1540 |
13.65 % |
Lung Cancer Drug Pipeline Update 2006
|
May 2007 |
£1015 |
13.5 % |
Injectable Generic Drugs
Prospects & Opportunities to 2013
|
July 2008 |
£1295 |
12.95 % |
Commercial and Pipeline Perspectives: Obesity
Lack of Reimbursement Limits Market Potential
|
December 2006 |
£6000 |
12.95 % |
Therapeutic Proteins
|
February 2005 |
£1999 |
12.95 % |
Cancer Antibodies
Competitive Positioning for Success
|
June 2008 |
£1535 |
11.9 % |
The Drug Target Atlas of Protein Kinase Inhibitors in Oncology
|
November 2007 |
£2495 |
11.9 % |
Angiogenesis Modulators
|
January 2008 |
£1390 |
11.2 % |
Women’s Health Diagnostic Tests
|
December 2004 |
£500 |
9.45 % |
Drug Delivery in Central Nervous System Diseases
technologies,markets and companies
|
September 2008 |
£1340 |
9.1 % |
Top 7 Cancer Indications
Therapeutic & Competitive Insights
|
January 2007 |
£4715 |
9.1 % |
Handbook of Pharmaceutical Manufacturing Formulations - Vol 2 of 6
Uncompressed Solid Products
|
April 2007 |
£195 |
8.05 % |
Cell Therapy
Technologies, Markets and Companies
|
September 2008 |
£2410 |
8.05 % |
Personalized Medicine
scientific & commercial aspects
|
September 2008 |
£2140 |
7.35 % |
|
|
|
|
